Brandinium

Trademark search for:

COMPASTEP

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2017-03-20 — Application filed
  • 2017-11-16 — Sn assigned for sect 66a appl from ib
  • 2017-11-22 — Application filed
  • 2017-11-22 — Assigned to examiner
  • 2017-11-28 — Application filed
  • 2017-11-30 — Final disposition recorded
  • 2017-12-01 — Office action issued
  • 2017-12-14 — Office action issued
  • 2017-12-14 — Office action issued
  • 2018-01-11 — Office action issued
  • 2018-06-14 — Office action issued
  • 2018-06-14 — Teas revoke/app/change addr of atty/dom rep received
  • 2018-06-14 — Attorney/dom.rep.revoked and/or appointed
  • 2018-06-28 — Assigned to lie
  • 2018-07-02 — Applicant/correspondence changes (non-responsive) entered
  • 2018-07-02 — Correspondence received in law office
  • 2018-07-02 — Teas/email correspondence entered
  • 2018-07-13 — Approved for pub - principal register
  • 2018-07-26 — Change of owner received from ib
  • 2018-08-01 — Notice of start of opposition period created, to be sent to ib
  • 2018-08-01 — Notification of notice of publication e-mailed
  • 2018-08-01 — Notification of possible opposition sent to ib
  • 2018-08-17 — Notification processed by ib
  • 2018-08-21 — Published for opposition
  • 2018-08-21 — Official gazette publication confirmation e-mailed
  • 2018-11-06 — Registered-principal register
  • 2019-02-06 — Final disposition recorded
  • 2019-02-12 — Final disposition recorded
  • 2019-02-12 — Final disposition recorded
  • 2019-03-01 — Final disposition recorded
  • 2020-01-02 — New representative at ib received
  • 2020-01-31 — Teas revoke/app/change addr of atty/dom rep received
  • 2020-01-31 — Attorney/dom.rep.revoked and/or appointed
  • 2023-03-03 — Change of owner received from ib
  • 2023-11-06 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2025-05-23 — Cancelled section 71
  • 2025-05-23 — Final status recorded

Owner Information

A. NATTERMANN & Cie GMBH
DE
Sanofi-Aventis Deutschland GmbH
DE
Sanofi-Aventis Deutschland GmbH
DE
Sanofi-Aventis Deutschland GmbH
DE
Boehringer Ingelheim International GmbH
DE

Correspondent

Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd St., 17th Fl.
New York, NY 10036
UNITED STATES

Filing Details

Filing Date:
2017-03-20
Status Date:
2025-05-23
Category:
Pharmaceuticals
Filing Year:
2017

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.